Sorafenib therapy demonstrated a survival benefit, yet with a borderline significance.
← all excerpts
Current state and clinical outcome in Turkish patients with hepatocellular carcinoma.
1
—
—
Sorafenib therapy demonstrated a survival benefit, yet with a borderline significance.